Inpatient Admission Form Not Available
If you need to send an inpatient notification to Group Health, please send it via our secure fax number: 206-901-6109.
Pharmacy News: July 2015 (PDF)
Asthma medication adherence, use of suvorexant, pharmacologic options for alcohol use disorder, and more.
Drugs Requiring Prior Authorization Approval
Effective Sept. 1, the following drugs require prior authorization:
Effective Sept. 1, nivolumab (Opdivo), pembrolizumab (Keytruda), and ramucirumab (Cyramza) will not be covered.
Highlights from the June 10 meeting.
Effective Aug. 1, the criteria for infliximab will include a change in prior authorization approval.
Check out Clinical Pearls recommendations you can integrate into your daily practice.
Effective Aug. 3, Group Health's process is changing for requesting a provider reconsideration when there is disagreement on the final disposition of a claim.
ICD-10 implementation, updated depression and tobacco use guidelines, new sleep disorders guideline, pharmacy updates, and more.
List identifying whether contracted hospitals are religiously affiliated. For questions about services, contact the hospitals or Dr. Paul Sherman at Group Health.
This member-approved advisory resolution reaffirm's Group Health's commitment to provide a full spectrum of legal, covered, and medically appropriate services, including reproductive health and end-of-life care.
For questions about your existing account, call OHP technical support at 1-800-973-4797.
Don't have an account? Visit OneHealthPort for more information.
Online Services Demos
Contractually binding information on this site.
Recommendations for clinicians and patients about specific clinical circumstances.
Fraud, Waste, Abuse (FWA) Prevention Training
To complete Group Health's training, review our